Abstract
Small-cell lung cancer (SCLC) accounts for 15%–20% of all lung cancer cases. It is a systemic disease that requires multidisciplinary management. Both chemotherapy and radiation therapy are important treatment modalities in curative and palliative treatment of SCLC.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albain KS, Crowley JJ, Livingston RB (1991) Long-term survival and toxicity in small-cell lung cancer. Expended Southwest Oncology Group experience. Chest 99: 1425–1432
Auperin A, Arriagada R, Pignon JP et al. (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341: 476–484
Beith JM, Clarke SJ, Woods RL et al. (1996) Long-term follow-up of a randomised trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lung. Eur J Cancer 32A: 438–443
Bogart J, Herndon J, Lyss AP et al. (2002) 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited stage small cell lung cancer: preliminary analysis of a CALGB phase II trial. Int J Radiat Oncol Biol Phys 54[2 suppl]:103
Bonner JA, Sloan JA, Shanahan TG et al. (1999) Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small cell lung carcinoma. J Clin Oncol 17: 2681–2691
Bradley JD, Dehdashti F, Mintun MA et al. (2004) Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J Clin Oncol 22:3248–3254
Brink I, Schumacher T, Mix M et al. (2004) Impact of [18F] FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 31:1614–1620
Byhardt RW, Hartz A, Libnoch JA et al. (1986) Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCLC). Int J Radiat Oncol Biol Physs 12:771–777
Byhardt RW, Martin L, Pajak TF et al. (1993) The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer — analysis of a Radiation Therapy Oncology Group protocol. Int J Radiat Oncol Biol Phys 27:537–544
Byrne MJ, van Hazel G, Trotter J et al. (1989) Maintenance chemotherapy in limited small-cell lung cancer: a randomized controlled clinical trial. Br J Cancer 60:413–418
Cerny T, Blair V, Anderson H, et al. (1987) Pretreatment prognostic factors and scoring system in 407 small cell lung cancer patients. Int J Cancer 39:146–149
Choi NC, Herndon JE 2nd, Rosenman J et al. (1998) Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. J Clin Oncol 16:3528–3536
Chute JP, Venzon DJ, Hankins L et al. (1997) Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute. Mayo Clin Proc 72:901–912
Claude L, Pérol D, Ginestet C et al. (2004) A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol 71:175–181
Curran WJ Jr. (2001) Combined-modality therapy for limited-stage small cell lung cancer. Semin Oncol 28[2 Suppl 4]:14–22
Dimopoulos MA, Fernandez JF, Samaan NA et al. (1984) Paraneoplastic Cushing’s syndrome as an adverse prognostic factor in patients who die early with small cell carcinoma of the lung. Am J Med 77:851–857
Emami B, Lyman J, Brown A et al. (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122
Giaccone G, Dalesio O, McVie GJ et al. (1993) Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 11:1230–1240
Govindan R, Page N, Morgensztern D et al. (2006) Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24:4539–4544
Gregor A, Cull A, Stephens RJ et al. (1997) Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomized trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 33:1752–1758
Jeremic B, Shibamoto Y, Acimovic L et al. (1997) Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol 15:893–900
Johnson BE, Patronas N, Hayes W et al. (1990) Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small-cell lung cancer: further follow-up of 6-to 13-year survivors. J Clin Oncol 8:48–56
Kies MS, Mira JG, Crowley JJ et al. (1987) Multimodal therapy for limited small cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders; a Southwest Oncology Group study. J Clin Oncol 5:592–600
Komaki R, Meyers CA, Shin DM et al. (1995) Evaluation of cognitive function in patients with limited small-cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 33:179–182
Kotalik J, Yu E, Markman BR et al. (2001) Practice guideline on prophylactic cranial irradiation in small-cell lung cancer. Int J Radiat Oncol Biol Phys 50:309–316
Liengswangwong V, Bonner JA, Shaw EG et al. (1994) Limited stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. J Clin Oncol 12:496–502
Line DH, Deeley TJ (1971) The necropsy findings in carcinoma of the bronchus. Br J Dis Chest 65:238–242
List AF, Hainsworth JD, Davis BW et al. (1986) The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small cell lung cancer. J Clin Oncol 4:1191–1198
Loehrer PJ Sr, Einhorn LH, Greco FA (1988) Cisplatin plus etoposide in small cell lung cancer. Semin Oncol 15[3 Suppl 3]:2–8
Movsas B, Raffin TA, Epstein AH et al. (1997) Pulmonary radiation injury. Chest 111:1061–1076
Murray N, Coy P, Pater JL et al. (1993) Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 11:336–344
National Comprehensive Cancer Network (2008) Clinical practice guidelines in oncology: small-cell lung cancer. Available at http://www.nccn.org/ Accessed on March 30, 2008
Paesmans M, Sculier JP, Lecomte J et al. (2000) Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years. Cancer 89:523–533
Pignon JP, Arriagada R, Ihde DC et al. (1992) A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327:1618–1624
Radiation Therapy Oncology Group (2007) Active lung cancer protocols. Available at http://www.rtog.org/members/active.html#lung. Accessed on October 23, 2007
Sculier JP, Paesmans M, Bureau G et al. (1996) Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party. J Clin Oncol 14:2337–2344
Shepherd FA, Ginsberg RJ, Patterson GA et al. (1989) A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study. J Thorac Cardiovasc Surg 97:177–186
Skarlos DV, Samantas E, Kosmidis P et al. (1994) Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study. Ann Oncol 5:601–607
Stahel RA, Ginsberg R, Havermann K et al (1989) Staging and prognostic factors in small cell lung cancer: a consensus. Lung Cancer 5:119–126
Sundstrøm S, Bremnes RM, Kaasa S et al. (2002) Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years’ follow-up. J Clin Oncol 20:4665–4672
Slotman B, Faivre-Finn C, Kramer G et al. (2007) Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 357:664–672
Suwinski R, Lee SP Withers HR (1998) Dose-response relationship for prophylactic cranial irradiation in small-cell lung cancer. Int J Radiat Oncol Biol Phys 40:797–806
Turrisi AT 3rd, Kim K, Blum R et al. (1999) Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340:265–271
Warde P, Payne D (1992) Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890–895
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lu, J.J. (2008). Small Cell Lung Cancer. In: Lu, J.J., Brady, L.W. (eds) Radiation Oncology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77385-6_10
Download citation
DOI: https://doi.org/10.1007/978-3-540-77385-6_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-77384-9
Online ISBN: 978-3-540-77385-6
eBook Packages: MedicineMedicine (R0)